Microba Life Sciences

🇦🇺 This Week in Australian Startups #179, 26th September 2026

Weekly roundup recording a dozen raises and acquisitions, Firmus's scheduled float, a new $50m venture fund, a founder share sale, grant winners, an accelerator intake, and an AI agent's government breach.

Also DealStreetAsia·Dealroom·This Week in Australian Startups·AFR Technology·AFR Technology·Startup Daily·AFR Technology·AFR Technology·ABC News Technology·iTnews

Three's a party! Medtech BCAL woos Genetic Signatures, Sonic's Microba

Street Talk reports BCAL Diagnostics' takeover plan for Genetic Signatures collapsed once the target's talks with Sonic-backed Microba surfaced, with a three-company combination now under discussion.

Genetic Signatures and Microba explore merger to build infectious disease diagnostics group

The two diagnostics companies have entered early-stage merger talks aiming to combine rapid pathogen testing with gut microbiome analysis, though both stress the discussions are preliminary with no terms agreed.

Meet FaBA's new Business Development and Commercialisation Director

FaBA introduces its newly appointed commercialisation director, who discusses his microbiome industry background and the accelerator's co-funded research projects for industry partners.

Manufacturing news briefs – stories you might have missed

Roundup of Australian manufacturing news: Matrak closes a Series A, Queensland Pacific Metals receives an R&D tax refund, ARENA funds a household energy trial, Ampcontrol appoints a transformation chief, plus policy and launch briefs.

Also @AuManufacturing

Convergence Medical gains FDA 'breakthrough' listing

Brisbane surgical-robotics startup Convergence Medical wins a US regulator's fast-track designation for its arthroscopic robot; the piece recalls two recent raises totalling $3 million and a new chief medical officer hire.

Insurer nib takes third bite of online scripts startup Midnight Health, pledging $24 million for 77% stake

Insurer nib has injected a further $15 million into Brisbane online prescriptions platform Midnight Health's Series B, lifting its holding to 77%, having backed the company since 2021; rival Eucalyptus recently banked $50 million.

Also Forbes Australia·Techboard

Insurer nib backs Queensland startup Midnight Health in $12 million Series A

Brisbane digital healthcare company Midnight Health has raised a Series A from insurer nib, valuing it at $48 million, following an earlier investment, with funds going to technology, staff and new product launches.

Also Startup Daily·SmartCompany

FUNDED APRIL 2022

Techboard's monthly roundup cataloguing April 2022 Australian startup funding: megadeals, seed rounds, grants and crowdfunding, nine acquisitions, several ASX listings, and venture firms' fund news.

FUNDED MARCH 2022

Techboard's March 2022 roundup of Australian funding: megadeals by Immutable, Saluda Medical, Linktree and Zeller, many smaller raises, acquisitions, an IPO, several fund closes, and companies still seeking capital.

Also SmartCompany·Australian FinTech

Thorney, Perennial back Microba’s gut feeling

Gut health biotech Microba has raised $10 million in its Series B round, backed by Thorney Investments, Perennial Value and Alium Capital, following Macrogen's separate $4.1 million investment announced the prior week.